Advancing microbiome therapeutics: Vedanta Biosciences raises US$45.5m in funding

The company has generated a pipeline of microbial treatment programs for infectious diseases, autoimmune diseases, allergies and cancer

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

12 Aug 2020 --- Nestlé Health Science (NHSc) and Israel-based biomedical company Epitomee have entered into a strategic partnership to develop and commercialize a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Aug 2020 --- Many allergies and food sensitivities are on the rise, with some consumers flagging difficulties digesting many dairy products, for example. As a result, industry... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 Aug 2020 --- With over half of Australia’s population experiencing gastrointestinal issues, healthcare professionals must have products that reflect the microbiome’s... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Aug 2020 --- European venture company Seventure Partners has revealed that the French government has approved the eligibility of its Health for Life Capital II (HFL 2) fund for... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

31 Jul 2020 --- Nestlé’s infant nutrition subsidiary Gerber is expanding its organic snacks range with the introduction of Gerber Organic BabyPops. The product is a... Read More

trans